AVTE logo

Aerovate Therapeutics (AVTE)

Profile

Full Name

Aerovate Therapeutics, Inc.

Ticker Symbol

AVTE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 30, 2021

Indexes

Not included

Website

http://www.aerovatetx.com

Employees

4

Key Details

Price

$2.68

Market cap

Last Dividend

$2.40

TTM Dividend yield

89.55%

Annual revenue

-

Annual EPS

-$2.44(+14.98% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.68
    AVTE price is $2.68

    30-Day Relative Volume

    22.20
    AVTE 30-day relative volume is 22.20

    Price Performance

    Price Most recent change

    -
    AVTE price change on Apr 28, 2025 is unknown

    Price YTD change

    -97.11%
    AVTE price is down -97.11% since January 1st

    Price 1-year change

    -99.62%
    AVTE price is down -99.62% year-on-year

    Price 3-year change

    -99.42%
    AVTE price is down -99.42% over the past 3 years

    Price Range

    Price All-time high

    $1076.25
    AVTE price is currently -99.75% below its historical high of $1076.25

    Price 3-year low

    $1.25
    AVTE price is currently +114.40% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $77.68M
    AVTE market capitalization is $77.68 million

    Market cap 3-year change

    -99.31%
    AVTE market capitalization is down -99.31% over the past 3 years

    Market cap All-time high

    $30.03B
    AVTE market capitalization is currently -99.74% below its historical high of $30.03 billion

    Market cap sector rank

    -
    AVTE market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.61%
    AVTE shares outstanding is up +0.61% year-on-year

    Shares Outstanding 3-Year Change

    +18.74%
    AVTE shares outstanding is up +18.74% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.10
    AVTE beta is 0.10

    200-day SMA

    $80.79
    AVTE price is currently -96.68% below its 200-day simple moving average

    50-day SMA

    $86.71
    AVTE price is currently -96.91% below its 50-day simple moving average

    RSI

    7.35
    AVTE 14-day relative strength index is 7.35

    Volume

    22.20
    AVTE 30-day relative volume is 22.20

    ATR

    $16.43
    AVTE average true range is $16.43

    10-day Historical Volatility

    488.53%
    AVTE 10-day historical volatility is 488.53%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $2.40
    AVTE last dividend was $2.40 per share, with an ex-dividend date of April 29, 2025

    Next Dividend

    -
    AVTE next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    AVTE annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    AVTE annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    AVTE annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    AVTE annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    AVTE annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    AVTE annual dividend yield is unknown

    Other

    Payout ratio

    -
    AVTE annual payout ratio value is unknown

    Dividends paid

    -
    AVTE annual dividends paid value is unknown

    Free cash flow

    -$71.20M
    AVTE annual free cash flow is -$71.20 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    AVTE annual revenue value is unknown

    Revenue Analysts estimate

    -
    AVTE annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    AVTE annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    AVTE annual revenue is unknown

    EPS

    EPS

    -$2.44
    AVTE annual earnings per share is -$2.44

    EPS Analysts estimate

    -$12.43
    AVTE annual earnings per share is currently -80.36% lower than the consensus analysts' forecast

    EPS 1-year change

    +14.98%
    AVTE annual earnings per share is up +14.98% year-on-year

    EPS Sector rank

    -
    AVTE annual earnings per share is unknown

    Profit

    Gross profit

    -
    AVTE annual gross profit value is unknown

    Gross margin

    -
    AVTE annual gross profit margin value is unknown

    Operating profit

    -$74.60M
    AVTE annual operating income is -$74.60 million

    Operating margin

    -
    AVTE annual operating profit margin value is unknown

    Net income

    -$69.63M
    AVTE annual net profit is -$69.63 million

    Net margin

    -
    AVTE annual net profit margin value is unknown

    Expenses

    Total expenses

    $74.60M
    AVTE annual total expenses is $74.60 million

    Operating expenses

    $74.60M
    AVTE annual total operating expenses is $74.60 million

    Cost of goods sold

    -
    AVTE annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $21.41M
    AVTE annual SGA is $21.41 million

    Depreciation and amortization

    $282.00K
    AVTE annual depreciation & amortization is $282.00 thousand

    Interest expense

    -
    AVTE annual interest expense value is unknown

    Income tax

    $55.00K
    AVTE annual income tax is $55.00 thousand

    EBIT & EBITDA

    EBIT

    -$74.60M
    AVTE annual earnings before interest & taxes is -$74.60 million

    EBITDA

    -$74.31M
    AVTE annual EBITDA is -$74.31 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $80.33M
    AVTE annual total assets is $80.33 million

    Non current assets

    $215.00K
    AVTE annual long term assets is $215.00 thousand

    Current assets

    $80.12M
    AVTE annual total current assets is $80.12 million

    Cash and cash equivalents

    $33.75M
    AVTE annual cash & cash equivalents is $33.75 million

    Accounts receivable

    -
    AVTE annual accounts receivable value is unknown

    Inventory

    -
    AVTE annual inventory value is unknown

    Liabilities

    Total liabilities

    $3.90M
    AVTE annual total liabilities is $3.90 million

    Long term liabilities

    $70.00K
    AVTE annual total long term liabilities is $70.00 thousand

    Current liabilities

    $3.83M
    AVTE annual total current liabilities is $3.83 million

    Accounts payable

    $224.00K
    AVTE annual accounts payable is $224.00 thousand

    Debt

    Total debt

    $417.00K
    AVTE annual total debt is $417.00 thousand

    Total debt 1-year change

    -38.22%
    AVTE annual total debt is down -38.22% year-on-year

    Long term debt

    $0.00
    AVTE annual long term debt is $0.00

    Short term debt

    $417.00K
    AVTE annual short term debt is $417.00 thousand

    Equity & Capital

    Shareholders equity

    $76.43M
    AVTE annual stockholders equity is $76.43 million

    Book value

    $76.43M
    AVTE annual book value is $76.43 million

    Retained earnings

    -$233.05M
    AVTE annual retained earnings is -$233.05 million

    Working capital

    $76.29M
    AVTE annual working capital is $76.29 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$71.20M
    AVTE annual cash flow from operations is -$71.20 million

    Cash from operations 1-year change

    -25.39%
    AVTE annual cash flow from operations is down -25.39% year-on-year

    Cash from investing

    $56.03M
    AVTE annual cash flow from investing activities is $56.03 million

    Cash from investing 1-year change

    +371.78%
    AVTE annual cash flow from investing activities is up +371.78% year-on-year

    Cash from financing

    $25.43M
    AVTE annual cash flow from financing activities is $25.43 million

    Cash from financing 1-year change

    -44.72%
    AVTE annual cash flow from financing activities is down -44.72% year-on-year

    CAPEX

    CAPEX

    -
    AVTE annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    AVTE annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$71.20M
    AVTE annual free cash flow is -$71.20 million

    Free cash flow 1-year change

    -25.08%
    AVTE annual free cash flow is down -25.08% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    AVTE annual gross profit margin value is unknown

    Operating margin

    -
    AVTE annual operating profit margin value is unknown

    Net margin

    -
    AVTE annual net profit margin value is unknown

    ROA & ROE

    ROA

    -86.68%
    AVTE annual return on assets is -86.68%

    ROE

    -91.10%
    AVTE annual return on equity is -91.10%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AVTE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AVTE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.04
    AVTE price to book ratio is 1.04

    PB ratio Sector rank

    -
    AVTE price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    AVTE price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AVTE price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $33.77M
    AVTE enterprise value is $33.77 million

    Enterprise value Sector rank

    -
    AVTE enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -0.64
    AVTE EV/EBITDA is -0.64

    EV/EBITDA Sector rank

    -
    AVTE EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    20.93
    AVTE annual current ratio is 20.93

    Quick ratio

    -
    AVTE annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.01
    AVTE annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    AVTE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    AVTE piotroski f-score value is unknown

    Altman Z-Score

    -
    AVTE altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 18, 24 Wells Fargo
    Equal-Weight
    Jun 18, 24 TD Cowen
    Hold
    Jun 18, 24 Guggenheim
    Neutral
    Jun 18, 24 Evercore ISI Group
    In-Line
    Jun 17, 24 Jefferies
    Hold
    Jun 17, 24 BTIG
    Neutral
    Jun 6, 24 Wedbush
    Outperform
    May 22, 24 Wedbush
    Outperform
    May 14, 24 Wedbush
    Outperform
    Apr 1, 24 Wells Fargo
    Overweight

    Institutional Ownership

    Screeners with AVTE included

    Stocks above SMA 50
    • What is the ticker symbol for Aerovate Therapeutics?
    • Does Aerovate Therapeutics pay dividends?
    • What sector is Aerovate Therapeutics in?
    • What industry is Aerovate Therapeutics in?
    • What country is Aerovate Therapeutics based in?
    • When did Aerovate Therapeutics go public?
    • Is Aerovate Therapeutics in the S&P 500?
    • Is Aerovate Therapeutics in the NASDAQ 100?
    • Is Aerovate Therapeutics in the Dow Jones?
    • When was Aerovate Therapeutics's last earnings report?
    • When does Aerovate Therapeutics report earnings?
    • Should I buy Aerovate Therapeutics stock now?

    What is the ticker symbol for Aerovate Therapeutics?

    The ticker symbol for Aerovate Therapeutics is NASDAQ:AVTE

    Does Aerovate Therapeutics pay dividends?

    Yes, Aerovate Therapeutics pays dividends. The last payment was $2.40, with an ex-dividend date on April 29, 2025

    What sector is Aerovate Therapeutics in?

    Aerovate Therapeutics is in the Healthcare sector

    What industry is Aerovate Therapeutics in?

    Aerovate Therapeutics is in the Biotechnology industry

    What country is Aerovate Therapeutics based in?

    Aerovate Therapeutics is headquartered in United States

    When did Aerovate Therapeutics go public?

    Aerovate Therapeutics's initial public offering (IPO) was on June 30, 2021

    Is Aerovate Therapeutics in the S&P 500?

    No, Aerovate Therapeutics is not included in the S&P 500 index

    Is Aerovate Therapeutics in the NASDAQ 100?

    No, Aerovate Therapeutics is not included in the NASDAQ 100 index

    Is Aerovate Therapeutics in the Dow Jones?

    No, Aerovate Therapeutics is not included in the Dow Jones index

    When was Aerovate Therapeutics's last earnings report?

    Aerovate Therapeutics's most recent earnings report was on May 13, 2025

    When does Aerovate Therapeutics report earnings?

    The date for Aerovate Therapeutics's next earnings report has not been announced yet

    Should I buy Aerovate Therapeutics stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page